Physician
Mountainview Pediatrics, P.C.
Mountainview Pediatrics, P.C. was paid $5.52M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoMOUNTAINVIEW PEDIATRICS, P.C.
MARION, VA 24354
MARION, VA 24354
33aNPI1528070216assigned 08/12/2006
33bProvider typePediatrics Physician
28Total paid$5.52M
24GClaims148,721
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#24 of 817
Median peer was paid$29K
This provider vs. median189×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,963 | $180K | |
| 2019 | 22,391 | $669K | |
| 2020 | 17,482 | $540K | |
| 2021 | 23,590 | $799K | |
| 2022 | 28,148 | $1.02M | |
| 2023 | 27,767 | $1.29M | |
| 2024incomplete | 22,380 | $1.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 33,616 | 30,158 | $1.97M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 15,977 | 14,601 | $1.36M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.9% | 2,821 | 2,653 | $325K |
| 87428 | 4.7% | 7,114 | 6,658 | $262K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.5% | 3,254 | 3,178 | $249K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.1% | 2,352 | 2,267 | $171K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.7% | 1,939 | 1,908 | $149K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 8,170 | 7,639 | $97K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 722 | 684 | $92K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 1,091 | 1,062 | $91K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 2,731 | 2,573 | $78K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 3,884 | 2,420 | $62K |
55 more codes
| 87430 | 1.1% | 4,725 | $60K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,463 | $54K |
| 90677 | <1% | 336 | $52K | |
| 92551 | <1% | 5,236 | $50K | |
| 90671 | <1% | 320 | $46K | |
| 90686 | <1% | 3,485 | $41K | |
| 96127 | <1% | 7,556 | $37K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 8,538 | $32K |
| 90670 | <1% | 1,196 | $22K | |
| 90723 | <1% | 1,027 | $22K | |
| 90648 | <1% | 1,651 | $18K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 398 | $16K |
| 90651 | <1% | 350 | $13K | |
| 87807 | <1% | 1,081 | $13K | |
| 99000 | <1% | 7,753 | $12K | |
| 99177 | <1% | 2,474 | $10K | |
| 90461 | <1% | 3,997 | $10K | |
| 99174 | <1% | 2,195 | $10K | |
| 90734 | <1% | 344 | $9K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 253 | $8K |
| 90681 | <1% | 238 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 159 | $6K |
| 90656 | <1% | 364 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 349 | $5K |
| 99188 | <1% | 239 | $5K | |
| 90633 | <1% | 346 | $5K | |
| 0001A | <1% | 117 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,550 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 478 | $4K |
| H0049 | Alcohol and/or drug screening | <1% | 794 | $4K |
| 0002A | <1% | 94 | $4K | |
| 90620 | <1% | 54 | $4K | |
| 95117 | <1% | 308 | $3K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 14 | $2K |
| 90710 | <1% | 80 | $2K | |
| 81003 | <1% | 966 | $2K | |
| 0071A | <1% | 48 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,159 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 129 | $2K |
| 0072A | <1% | 43 | $2K | |
| 99442 | <1% | 43 | $2K | |
| 87420 | <1% | 130 | $1K | |
| 90715 | <1% | 80 | $965.71 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 49 | $815.24 |
| 90696 | <1% | 52 | $682.62 | |
| 96161 | <1% | 462 | $648.41 | |
| 96380 | <1% | 43 | $407.24 | |
| 85018 | <1% | 148 | $353.84 | |
| 36416 | <1% | 1,362 | $299.05 | |
| 83655 | <1% | 28 | $266.41 | |
| 86308 | <1% | 49 | $219.24 | |
| 96160 | <1% | 181 | $135.71 | |
| 91300 | <1% | 344 | $3.19 | |
| 91307 | <1% | 160 | $1.18 | |
| 91305 | <1% | 12 | $0.07 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHEETS, GINGER (PRACTICE MANAGER)